Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Tatyana N. Soluyanova"'
Autor:
Marina G. Rusanova, Maria V. Otpushchennikova, Nataliya E. Kostina, Alexander A. Garbuzov, Antonina A. Ploskireva, Tatiana A. Ruzhentsova, Viсtoria S. Lesina, Moscow Jsc 'R-Pharm', Dmitriy A. Bistritskiy, Тatyana N. Markova, Viсtoria A. Razzhivina, Emilia N. Krasavina, Llc 'Mc Eco-safety', Alina S. Agaf'ina, Dzhavanshir M. Mustafaev, Tatyana N. Soluyanova, Rodion A. Oseshnyuk, Llc 'Neuroprofi', Yury F. Brook, Daria A. Khavkina, Olga V. Filon, Human Well-being Surveillance\\', Arkadiy V. Zintchenko, Oleg Yu. Bronov, Mikhail Yu. Samsonov, Konstantin A. Pokrovskiy, Tatiana N. Domostroeva, Adel Yu. Vafin, Sergey G. Shcherbak, Pavel V. Chukhlyaev, Elena P. Dmitrikova, Elena A. Kaplun, Evgeny I. Shults, Irina V. Shestakova, Diana V. Petina, Mariya V. Nikolskaya
Publikováno v:
Infectious diseases: News, Opinions, Training. 9:26-38
Material and methods An open-labeled, randomized, active-controlled multicenter trial of favipiravir in out- and hospitalized patients with mild to moderate COVID-19 was conducted Eligible patients were aged 18-60 years and had laboratory confirmed b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77c6a70b4eb8b78862c34d91995219d7
https://doi.org/10.33029/2305-3496-2020-9-4-26-38
https://doi.org/10.33029/2305-3496-2020-9-4-26-38
